Danaher (DHR) Revenue & Revenue Breakdown
Danaher Revenue Highlights
Latest Revenue (Y)
$23.88B
Latest Revenue (Q)
$6.05B
Main Segment (Y)
Revenue from Contract with Customer, Measurement, Recurring
Main Geography (Y)
Other developed markets
Danaher Revenue by Period
Danaher Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $23.88B | -0.06% |
| 2023-12-31 | $23.89B | -24.09% |
| 2022-12-31 | $31.47B | 6.85% |
| 2021-12-31 | $29.45B | 32.17% |
| 2020-12-31 | $22.28B | 24.41% |
| 2019-12-31 | $17.91B | -9.96% |
| 2018-12-31 | $19.89B | 8.53% |
| 2017-12-31 | $18.33B | 8.57% |
| 2016-12-31 | $16.88B | -17.90% |
| 2015-12-31 | $20.56B | 3.26% |
| 2014-12-31 | $19.91B | 4.16% |
| 2013-12-31 | $19.12B | 4.70% |
| 2012-12-31 | $18.26B | 13.49% |
| 2011-12-31 | $16.09B | 21.87% |
| 2010-12-31 | $13.20B | 18.04% |
| 2009-12-31 | $11.18B | -11.91% |
| 2008-12-31 | $12.70B | 15.16% |
| 2007-12-31 | $11.03B | 14.90% |
| 2006-12-31 | $9.60B | 20.18% |
| 2005-12-31 | $7.98B | 15.90% |
| 2004-12-31 | $6.89B | 30.14% |
| 2003-12-31 | $5.29B | 15.66% |
| 2002-12-31 | $4.58B | 21.01% |
| 2001-12-31 | $3.78B | 0.12% |
| 2000-12-31 | $3.78B | 18.16% |
| 1999-12-31 | $3.20B | 9.87% |
| 1998-12-31 | $2.91B | 41.88% |
| 1997-12-31 | $2.05B | 13.20% |
| 1996-12-31 | $1.81B | 21.87% |
| 1995-12-31 | $1.49B | 15.37% |
| 1994-12-31 | $1.29B | 20.77% |
| 1993-12-31 | $1.07B | - |
Danaher generated $23.88B in revenue during NA 2024, up -0.06% compared to the previous quarter, and up 133.30% compared to the same period a year ago.
Danaher Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-26 | $6.05B | 1.97% |
| 2025-06-27 | $5.94B | 3.40% |
| 2025-03-28 | $5.74B | -12.19% |
| 2024-12-31 | $6.54B | 12.76% |
| 2024-09-27 | $5.80B | 0.96% |
| 2024-06-28 | $5.74B | -0.91% |
| 2024-03-29 | $5.80B | -9.51% |
| 2023-12-31 | $6.41B | 13.89% |
| 2023-09-29 | $5.62B | -21.42% |
| 2023-06-30 | $7.16B | 20.31% |
| 2023-03-31 | $5.95B | -16.61% |
| 2022-12-31 | $7.13B | -6.90% |
| 2022-09-30 | $7.66B | -1.14% |
| 2022-07-01 | $7.75B | 0.82% |
| 2022-04-01 | $7.69B | -5.65% |
| 2021-12-31 | $8.15B | 12.71% |
| 2021-10-01 | $7.23B | 0.15% |
| 2021-07-02 | $7.22B | 5.25% |
| 2021-04-02 | $6.86B | 1.45% |
| 2020-12-31 | $6.76B | 14.90% |
| 2020-10-02 | $5.88B | 11.06% |
| 2020-07-03 | $5.30B | 21.97% |
| 2020-04-03 | $4.34B | -10.79% |
| 2019-12-31 | $4.87B | 11.20% |
| 2019-09-27 | $4.38B | -1.50% |
| 2019-06-28 | $4.44B | 5.31% |
| 2019-03-29 | $4.22B | -8.35% |
| 2018-12-31 | $4.60B | -5.12% |
| 2018-09-28 | $4.85B | -2.57% |
| 2018-06-29 | $4.98B | 6.08% |
| 2018-03-30 | $4.70B | -7.67% |
| 2017-12-31 | $5.09B | 12.31% |
| 2017-09-29 | $4.53B | 0.40% |
| 2017-06-30 | $4.51B | 7.24% |
| 2017-03-31 | $4.21B | -8.26% |
| 2016-12-31 | $4.58B | 10.94% |
| 2016-09-30 | $4.13B | -28.57% |
| 2016-07-01 | $5.79B | 7.38% |
| 2016-04-01 | $5.39B | -8.46% |
| 2015-12-31 | $5.88B | 17.15% |
| 2015-10-02 | $5.02B | -2.02% |
| 2015-07-03 | $5.13B | 5.21% |
| 2015-04-03 | $4.87B | -10.04% |
| 2014-12-31 | $5.42B | 11.23% |
| 2014-09-26 | $4.87B | -1.88% |
| 2014-06-27 | $4.96B | 6.45% |
| 2014-03-28 | $4.66B | -11.47% |
| 2013-12-31 | $5.27B | 12.80% |
| 2013-09-27 | $4.67B | -1.44% |
| 2013-06-28 | $4.74B | 6.59% |
| 2013-03-29 | $4.44B | -10.66% |
| 2012-12-31 | $4.98B | 12.67% |
| 2012-09-28 | $4.42B | -3.03% |
| 2012-06-29 | $4.55B | 5.50% |
| 2012-03-30 | $4.32B | -4.40% |
| 2011-12-31 | $4.52B | -0.07% |
| 2011-09-30 | $4.52B | 21.73% |
| 2011-07-01 | $3.71B | 10.94% |
| 2011-04-01 | $3.35B | -7.30% |
| 2010-12-31 | $3.61B | 13.14% |
| 2010-10-01 | $3.19B | -3.65% |
| 2010-07-02 | $3.31B | 7.07% |
| 2010-04-02 | $3.09B | -1.30% |
| 2009-12-31 | $3.13B | 13.89% |
| 2009-10-02 | $2.75B | 2.88% |
| 2009-07-03 | $2.67B | 1.75% |
| 2009-04-03 | $2.63B | -17.28% |
| 2008-12-31 | $3.18B | -0.99% |
| 2008-09-26 | $3.21B | -2.31% |
| 2008-06-27 | $3.28B | 8.42% |
| 2008-03-28 | $3.03B | - |
Danaher generated $6.05B in revenue during Q3 2025, up 1.97% compared to the previous quarter, and up 105.40% compared to the same period a year ago.
Danaher Revenue Breakdown
Danaher Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Revenue from Contract with Customer, Measurement, Nonrecurring | $4.51B | $5.21B | - | - | - |
| Revenue from Contract with Customer, Measurement, Recurring | $19.37B | $18.68B | - | - | - |
| Analytical And Physical Instrumentation | - | - | $2.85B | $2.62B | $2.44B |
| Product Identification | - | - | $1.98B | $2.03B | $1.86B |
| Research and medical products | - | - | $26.64B | $24.80B | $17.98B |
Danaher's latest annual revenue breakdown by segment (product or service), as of Dec 24: Revenue from Contract with Customer, Measurement, Recurring (81.11%), and Revenue from Contract with Customer, Measurement, Nonrecurring (18.89%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Apr 22 | Dec 21 | Oct 21 | Jul 21 | Apr 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Contract with Customer, Measurement, Nonrecurring | $1.04B | $966.00M | $925.00M | $1.43B | $1.02B | $1.05B | $1.00B | - | $1.69B | $1.82B | $1.78B | $2.27B | $1.84B | $1.86B | $1.79B | $2.17B | $1.81B | $1.90B | $1.78B | $2.03B |
| Revenue from Contract with Customer, Measurement, Recurring | $5.02B | $4.97B | $4.82B | $5.11B | $4.78B | $4.69B | $4.79B | $2.78B | $5.18B | $5.34B | $5.39B | $6.10B | $5.83B | $5.89B | $5.90B | $5.98B | $5.42B | $5.32B | $5.08B | $4.73B |
Danaher's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Revenue from Contract with Customer, Measurement, Recurring (82.88%), and Revenue from Contract with Customer, Measurement, Nonrecurring (17.12%).
Danaher Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| North America | $9.93B | $9.96B | $13.37B | - | - |
| Other developed markets | $11.14B | $1.27B | $12.64B | - | - |
| CHINA | $2.81B | $4.00B | $3.98B | $2.69B | - |
| High-growth markets | - | $7.19B | - | - | - |
| Western Europe | - | $5.47B | $6.91B | - | - |
| GERMANY | - | - | $1.46B | $1.48B | $1.24B |
| All Other Countries | - | - | - | $12.71B | $9.74B |
| UNITED STATES | - | - | - | $11.28B | $8.62B |
Danaher's latest annual revenue breakdown by geography, as of Dec 24: Other developed markets (46.67%), North America (41.58%), and CHINA (11.75%).
Quarterly Revenue by Country
| Country | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Apr 22 | Dec 21 | Oct 21 | Jul 21 | Apr 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Western Europe | $1.40B | $1.51B | $1.34B | $1.32B | $1.32B | $1.32B | $585.00M | $1.47B | $1.71B | $1.71B | $1.85B | $1.54B | $1.69B | $1.83B | $1.86B | $1.67B | $1.77B | $1.66B | $1.67B | - |
| North America | $2.58B | $2.44B | $2.58B | $2.40B | $2.46B | $2.43B | $2.63B | $1.04B | $2.97B | $2.93B | $3.02B | $3.75B | $3.48B | $3.38B | $3.35B | $3.40B | $2.89B | $2.82B | $2.73B | $2.62B |
| High-growth markets | - | $1.70B | $1.72B | $1.70B | $1.54B | $810.00M | $2.10B | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other developed markets | - | $294.00M | $10.25B | $299.00M | $292.00M | $303.00M | $260.00M | $330.00M | - | - | - | - | - | - | - | - | - | - | - | - |
Danaher's latest quarterly revenue breakdown by geography, as of Sep 25: North America (64.89%), and Western Europe (35.11%).
Danaher Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MCK | McKesson | $308.95B | $97.83B |
| PFE | Pfizer | $63.63B | $14.65B |
| SNY | Sanofi | $43.07B | $11.12B |
| TMO | Thermo Fisher Scientific | $42.88B | $10.86B |
| MDT | Medtronic | $33.54B | $8.58B |
| AMGN | Amgen | $33.42B | $9.18B |
| GILD | Gilead Sciences | $28.75B | $6.67B |
| DHR | Danaher | $23.88B | $6.05B |
| SYK | Stryker | $22.59B | $6.02B |
| BSX | Boston Scientific | $16.75B | $5.06B |
| ISRG | Intuitive Surgical | $8.35B | $2.51B |